Company / Operating Margin
GT Biopharma, Inc. Operating Margin History
FY2011-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-33063.0%
FY2016
5-year range
-33063.0% / -215.5%
FY2012-FY2016
Trend
-741.8%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -742% YoY in FY2016, a notable deviation from the 5-year average annual change of -452%.
Based on SEC 10-K filings.
-33063.0% in FY2016 with a 5-year CAGR of -10363.0%.
Declined from -215.5% to -33063.0% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -32035.5pp
- 5-Year Change
- -10363.0pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, operating margin decreased 741.8% year-over-year.
- Peak operating margin was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2017 | - | - |
| FY2016 | -33063.0% | -741.8% |
| FY2015 | -3927.9% | -1722.8% |
| FY2014 | -215.5% | +79.0% |
| FY2013 | -1027.5% | +93.2% |
| FY2012 | -15107.7% | +33.4% |
| FY2011 | -22700.0% | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026